BIOHESION Trademark

Trademark Overview

On Monday, April 3, 2006, a trademark application was filed for BIOHESION with the United States Patent and Trademark Office. The USPTO has given the BIOHESION trademark a serial number of 78852933. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 20, 2015. This trademark is owned by BioHesion, Inc.. The BIOHESION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Custom biological cloning of recombinant DNA in host cells; protein expression services, namely, protein production in host cells through genetic engineering
biohesion

General Information

Serial Number78852933
Word MarkBIOHESION
Filing DateMonday, April 3, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 20, 2015
Registration Number3607703
Registration DateTuesday, April 14, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2006

Trademark Statements

Goods and ServicesCustom biological cloning of recombinant DNA in host cells; protein expression services, namely, protein production in host cells through genetic engineering

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 20, 2015
Primary Code042
First Use Anywhere DateSunday, December 1, 2002
First Use In Commerce DateSunday, December 1, 2002

Trademark Owner History

Party NameBioHesion, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98125
Party NameBioHesion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98125
Party NameBioHesion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98125

Trademark Events

Event DateEvent Description
Friday, November 20, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, April 14, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 10, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, March 10, 2009ASSIGNED TO LIE
Tuesday, March 10, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 13, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 12, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 12, 2009TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, September 3, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 3, 2008FINAL REFUSAL E-MAILED
Wednesday, September 3, 2008SU - FINAL REFUSAL - WRITTEN
Tuesday, May 13, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 13, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 13, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 15, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 15, 2007NON-FINAL ACTION E-MAILED
Thursday, November 15, 2007SU - NON-FINAL ACTION - WRITTEN
Wednesday, September 26, 2007STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 12, 2007USE AMENDMENT FILED
Wednesday, September 12, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, March 13, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 19, 2006PUBLISHED FOR OPPOSITION
Wednesday, November 29, 2006NOTICE OF PUBLICATION
Sunday, November 12, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 3, 2006ASSIGNED TO LIE
Saturday, October 28, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 10, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 5, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 5, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 22, 2006NON-FINAL ACTION E-MAILED
Friday, September 22, 2006NON-FINAL ACTION WRITTEN
Thursday, September 14, 2006ASSIGNED TO EXAMINER
Friday, April 7, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

biohesion cells host protein production through genetic engineering namely services cloning